1. Home
  2. PRCH vs WGS Comparison

PRCH vs WGS Comparison

Compare PRCH & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Porch Group Inc.

PRCH

Porch Group Inc.

N/A

Current Price

$17.06

Market Cap

1.5B

Sector

Technology

ML Signal

N/A

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$85.19

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRCH
WGS
Founded
2012
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
PRCH
WGS
Price
$17.06
$85.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
7
Target Price
$18.63
$120.71
AVG Volume (30 Days)
1.8M
776.7K
Earning Date
04-28-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
90.91
62.37
EPS
0.01
N/A
Revenue
$482,414,000.00
$427,539,000.00
Revenue This Year
$4.15
$29.98
Revenue Next Year
$17.05
$25.92
P/E Ratio
$1,709.00
N/A
Revenue Growth
10.18
39.97
52 Week Low
$6.36
$32.21
52 Week High
$19.44
$170.87

Technical Indicators

Market Signals
Indicator
PRCH
WGS
Relative Strength Index (RSI) 65.65 67.65
Support Level $9.08 $81.55
Resistance Level N/A $96.34
Average True Range (ATR) 0.73 4.48
MACD 0.05 0.79
Stochastic Oscillator 83.97 92.93

Price Performance

Historical Comparison
PRCH
WGS

About PRCH Porch Group Inc.

Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has four reportable segments: Insurance Services, Software & Data, Consumer Services, and Corporate. The majority of revenue is from the Insurance segment. The Insurance Services segment manages and operates the Reciprocal, providing services related, but not limited, to underwriting, policy renewal, risk management, insurance portfolio management, financial management, and setting investment guidelines in exchange for commissions and fees.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: